Journal article · 2026 · Open access

NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation

Daniel A. Okin, Joon H. Choi, Chun Wang, Cao Anh, Daniel Fisch, Weiyi Ma, Katherine E. Lindblad, Marta Valenti, Tristan Kooistra, Trong Nguyen, Lida P. Hariri, Neha Chaudhary and 5 more

Nature · Published 11 November 2026 · DOI 10.1038/s41586-026-11324-7

Open PDFView at the publisherCite this paper

In brief

“NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation” is a 2026 journal article by Daniel A. Okin and 16 co-authors, published in Nature. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Nature.

Citations
0
References
87
Authors
17

Abstract

Disconnects between in vitro and in vivo results in experimental biology have long been recognized as potential hurdles to understanding health and disease. A prototypical example of such a disconnect is the NLRP3 inflammasome, which mediates inflammation in diverse settings of disease and protective immunity1,2. Activation of the NLRP3 inflammasome in vitro requires two signals: (1) priming by pathogen-associated molecular patterns such as bacterial lipopolysaccharides and (2) activation by molecules that disrupt cellular homeostasis1,3. By contrast, the NLRP3 inflammasome in vivo is activated by lipopolysaccharide alone. The mechanisms that underlie the difference between in vitro and in vivo activation of the NLRP3 inflammasome are undefined. Here we report that extracellular matrix (ECM) stiffness is a determinant of NLRP3 activities and that in vitro systems using physiological ECM stiffness enable one-signal in vivo-like NLRP3 activities to occur in human and mouse phagocytes. Physiological ECM stiffness induced expression of the transcription factor NRF2, which was found to be necessary for one-signal NLRP3 activation. Mechanistically, we identify Panx1 as an NRF2-regulated gene that promotes NLRP3 activity. Macrophages derived from the stiff matrix of the bone—osteoclasts—had reduced NRF2 levels and impaired NLRP3 activity. Moreover, alveolar macrophages from patients with pulmonary fibrosis displayed reduced NRF2 activity. Finally, NRF2 was required for antitumour immunity induced by cancer vaccines consisting of NLRP3 agonistic adjuvants. These findings indicate that NRF2 may be a transcriptional checkpoint that controls NLRP3 inflammasome activity. The stiffness of the extracellular matrix is identified as a pivotal factor that influences activation of the NLRP3 inflammasome in vitro and in vivo.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Okin, D. A., Choi, J. H., Wang, C., Anh, C., Fisch, D., Ma, W., Lindblad, K. E., Valenti, M., Kooistra, T., Nguyen, T., Hariri, L. P., Chaudhary, N., Tien, Y.-C., da Silva, H. B., Knipe, R. S., Mbalaviele, G., & Kagan, J. C. (2026). NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation. Nature. https://doi.org/10.1038/s41586-026-11324-7

MLA 9

Okin, Daniel A., et al. “NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation.” Nature, 2026. https://doi.org/10.1038/s41586-026-11324-7.

Chicago

Okin, Daniel A., Joon H. Choi, Chun Wang, Cao Anh, Daniel Fisch, Weiyi Ma, Katherine E. Lindblad, et al. 2026. “NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation.” Nature. https://doi.org/10.1038/s41586-026-11324-7.

Harvard

Okin, D. A. et al. (2026) ‘NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation’, Nature. doi:10.1038/s41586-026-11324-7.

IEEE

D. A. Okin et al., “NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation,” Nature, 2026, doi: 10.1038/s41586-026-11324-7.

BibTeX

@article{okin2026mechanosensitive,
  title     = {{NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation}},
  author    = {Okin, Daniel A. and Choi, Joon H. and Wang, Chun and Anh, Cao and Fisch, Daniel and Ma, Weiyi and Lindblad, Katherine E. and Valenti, Marta and Kooistra, Tristan and Nguyen, Trong and Hariri, Lida P. and Chaudhary, Neha and Tien, Yun-Chen and da Silva, Henrique Borges and Knipe, Rachel S. and Mbalaviele, Gabriel and Kagan, Jonathan C.},
  journal   = {Nature},
  year      = {2026},
  doi       = {10.1038/s41586-026-11324-7},
  url       = {https://doi.org/10.1038/s41586-026-11324-7}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders

  • Nrf2
  • NLRP3 inflammasome
  • extracellular matrix stiffness
  • mechanosensing
  • pannexin 1
  • macrophages
  • osteoclasts
  • alveolar macrophages

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Okin, D. A., Choi, J. H., Wang, C., Anh, C., Fisch, D., Ma, W., Lindblad, K. E., Valenti, M., Kooistra, T., Nguyen, T., Hariri, L. P., Chaudhary, N., Tien, Y.-C., da Silva, H. B., Knipe, R. S., Mbalaviele, G., & Kagan, J. C. (2026). NRF2 is a mechanosensitive checkpoint for NLRP3 inflammasome activation. Nature. https://doi.org/10.1038/s41586-026-11324-7

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature: sign in and open the PDF from this page.

Who wrote this paper?

Daniel A. Okin, Joon H. Choi, Chun Wang, Cao Anh, Daniel Fisch, Weiyi Ma, Katherine E. Lindblad, Marta Valenti, Tristan Kooistra, Trong Nguyen, Lida P. Hariri, Neha Chaudhary and 5 more.

What is the DOI of this paper?

10.1038/s41586-026-11324-7, permanently at https://doi.org/10.1038/s41586-026-11324-7. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.